AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Mar 21 2024
News
Merck combination treatment for lung cancer fails late-stage study
The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo Purchase Licensing Rights , opens new tab March 21 (Reuters) - Merck (MRK.N) said on Thursday a combination of its cancer drugs Keytruda and Lynparza failed to meet the main goals of a late-stage study evaluating it as an initial treatment for a type of
ReutersFeb 05 2024
News
Merck & Co. Inc. stock outperforms competitors despite losses on the day
Shares of Merck & Co. Inc. MRK, sank 0.18% to $126.18 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX, falling 0.32% to 4,942.81 and Dow Jones Industrial Average DJIA, falling 0.71% to 38,380.12. Merck & Co. Inc. closed $1.38 short of its 52-week high ($127.56), which the company achieved on February 2nd. Despite its
MarketWatchJan 30 2024
News
Merck & Co. Inc. stock outperforms competitors on strong trading day
Shares of Merck & Co. Inc. MRK, inched 0.31% higher to $121.66 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA, rising 0.35% to 38,467.31 and the S&P 500 Index SPX, falling 0.06% to 4,924.97. This was the stock's fourth consecutive day of gains. Merck & Co. Inc. hit a new 52-week high, surpassing its
MarketWatchJan 18 2024
News
Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices
Senate health committee chair Bernie Sanders has taken a step toward subpoenaing the CEOs of Johnson & Johnson and Merck related to an investigation into high drug prices in the United States, he announced Thursday.
The step is highly unusual, as the health committee hasn’t issued a subpoena in more than 40 years.
STATJun 06 2023
News
Merck sues government over drug price negotiation
Drugmaker Merck & Co. Inc. sued the federal government Tuesday, seeking an injunction against parts of last year's reconciliation law that allow the Health and Human Services Department to negotiate for lower prices on drugs.
The lawsuit, filed in the U.S. District Court for the District of Columbia, argues that the negotiation program is “extortion” and violates the Fifth Amendment
Roll CallApr 16 2023
News
Merck to buy Prometheus Biosciences for about $11 billion
Merck & Co (MRK.N) has agreed to acquire Prometheus Biosciences Inc (RXDX.O) for about $10.8 billion to bolster the company's presence in immunology, the companies said on Sunday.
The joint statement said that Merck, through one of its subsidiaries, will pay $200 per share for the biotechnology company that specializes in products for treatment of immunological diseases. That
ReutersJun 07 2023
News
Merck lawsuit opens new effort to cripple drug price negotiations
Merck's lawsuit challenging drug price negotiations established by the Inflation Reduction Act is the likely start of a flurry of litigation to undo Democrats' signature effort to tackle pharmaceutical costs. Why it matters: At a minimum, the IRA's drug pricing provisions probably won’t start on time, experts say. And a Merck victory could cripple the way the law forces manufacturers to the
AxiosOct 17 2021
Data
Merck, Pfizer COVID-19 Antivirals Different From Ivermectin
Merck and Pfizer are each developing a new oral antiviral drug that might prevent or treat COVID-19. The pills are very different from the antiparasitic medication ivermectin, contrary to claims online that they are “suspiciously similar” or that the companies are “repackaging” ivermectin in a ploy to increase profits.
Throughout the COVID-19 pandemic, there has not been an easy-to-take
FactCheck.orgNov 16 2021
News
8 lingering questions about the new Covid pills from Merck and Pfizer
The past two months have brought extremely good news in the fight against Covid-19. Two different oral treatments have proved effective at both preventing people newly diagnosed with Covid-19 from entering the hospital and from dying.
“We’re accelerating our path out of this pandemic,” President Biden said after data on the second Covid pill became available. The wide availability of
STATOct 01 2021
News
Merck says experimental pill cuts worst effects of COVID-19
Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus, potentially a leap forward in the global fight against the pandemic.
The company said it will soon ask health officials in the U.S. and around the world to authorize the pill’s use. A decision from the U.S. Food and Drug
Associated Press